Published in Virology on March 15, 2003
HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology (2008) 3.72
Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases. J Virol (2005) 2.17
Uracil DNA glycosylase is dispensable for human immunodeficiency virus type 1 replication and does not contribute to the antiviral effects of the cytidine deaminase Apobec3G. J Virol (2006) 1.98
Plunder and stowaways: incorporation of cellular proteins by enveloped viruses. J Virol (2005) 1.56
Abundant non-canonical dUTP found in primary human macrophages drives its frequent incorporation by HIV-1 reverse transcriptase. J Biol Chem (2011) 0.95
Uracil within DNA: an actor of antiviral immunity. Retrovirology (2008) 0.89
X4 and R5 HIV-1 have distinct post-entry requirements for uracil DNA glycosylase during infection of primary cells. J Biol Chem (2010) 0.89
Uracil DNA Glycosylase 2 negatively regulates HIV-1 LTR transcription. Nucleic Acids Res (2009) 0.87
Cellular kinases incorporated into HIV-1 particles: passive or active passengers? Retrovirology (2011) 0.85
Vpr overcomes macrophage-specific restriction of HIV-1 Env expression and virion production. Cell Host Microbe (2014) 0.84
dUTPase: the frequently overlooked enzyme encoded by many retroviruses. Retrovirology (2015) 0.78
The dUTPase-related gene of bovine immunodeficiency virus is critical for viral replication, despite the lack of dUTPase activity of the encoded protein. Retrovirology (2014) 0.76
Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. Biochem J (2008) 1.77
Recombinase, chromosomal translocations and lymphoid neoplasia: targeting mistakes and repair failures. DNA Repair (Amst) (2006) 1.76
Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis. J Exp Med (2006) 1.43
HIV-1-associated uracil DNA glycosylase activity controls dUTP misincorporation in viral DNA and is essential to the HIV-1 life cycle. Mol Cell (2005) 1.42
A loss of viral replicative capacity correlates with altered DNA polymerization kinetics by the human immunodeficiency virus reverse transcriptase bearing the K65R and L74V dideoxynucleoside resistance substitutions. J Biol Chem (2004) 1.30
Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia. Blood (2011) 1.20
Agricultural pesticide exposure and the molecular connection to lymphomagenesis. J Exp Med (2009) 1.10
Isolation of proteinase K-sensitive prions using pronase E and phosphotungstic acid. PLoS One (2010) 1.06
The human polycomb group EED protein interacts with the integrase of human immunodeficiency virus type 1. J Virol (2003) 1.04
Synthetic Vpr protein activates activator protein-1, c-Jun N-terminal kinase, and NF-kappaB and stimulates HIV-1 transcription in promonocytic cells and primary macrophages. J Biol Chem (2005) 1.03
Spontaneous generation of mammalian prions. Proc Natl Acad Sci U S A (2010) 1.00
Uracils as a cellular weapon against viruses and mechanisms of viral escape. Curr HIV Res (2006) 0.97
Synthesis, in vitro antiviral evaluation, and stability studies of novel alpha-borano-nucleotide analogues of 9-[2-(phosphonomethoxy)ethyl]adenine and (R)-9-[2-(phosphonomethoxy)propyl]adenine. J Med Chem (2006) 0.97
Reversion of the lethal phenotype of an HIV-1 integrase mutant virus by overexpression of the same integrase mutant protein. J Biol Chem (2003) 0.92
In vivo reinsertion of excised episomes by the V(D)J recombinase: a potential threat to genomic stability. PLoS Biol (2007) 0.92
Nonstructural NS1 proteins of several mosquito-borne Flavivirus do not inhibit TLR3 signaling. Virology (2010) 0.90
Functional role of HIV-1 virion-associated uracil DNA glycosylase 2 in the correction of G:U mispairs to G:C pairs. J Biol Chem (2002) 0.90
Uracil within DNA: an actor of antiviral immunity. Retrovirology (2008) 0.89
Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression. J Clin Invest (2014) 0.85
MYC fails to efficiently shape malignant transformation in T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer (2013) 0.78
Synthesis and antiviral activity of boranophosphonate isosteres of AZT and d4T monophosphates. Eur J Med Chem (2009) 0.77